Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years

Introduction: Low-dose computed tomography (LD-CT) screening can reduce lung cancer mortality; however, it is essential to improve nodule management protocols. We analyze the performance of the diagnostic protocol of the Continuous Observation of SMOking Subjects single-center screening study, after long-term follow-up. Methods: Between 2004 and 2005, 5203 asymptomatic high-risk individuals (≥20 pack-years, aged 50 years or older) were enrolled to undergo annual LD-CT for 5 years. Nodules 5 mm or smaller underwent repeat LD-CT a year later. Nodules larger than 5.0 mm and 8.0 mm or smaller received LD-CT 3 to 6 months later. Nodules larger than 8.0 mm or growing underwent CT-positron emission tomography. True positives were any stage prevalent lung cancer, progressing nodules diagnosed at stage 1, localized multifocal cancer, or new nodules diagnosed at any stage. False negatives were progressing nodules diagnosed at stage >1. False positives were benign nodules resected surgically. Results: Compliance was 79% over 5 years; 175 primary lung cancers were detected (0.76% per year), 136 (77.7%) were N0M0 and three were interval cancers. Eleven second primary lung cancers were diagnosed. Resectability was 87.4%; postoperative mortality 0.6%. Recall was 6.4% overall, 10.1% at baseline. False negatives were 14 of 175 (8%). Protocol sensitivity was 158 of 175 (90%); specificity 4994 of 5028 (99.4%); positive predictive value was 158 of 187 (84.5%); and negative predictive value was 4994 of 5016 (99.7%). Twenty-nine of 204 (14.2%) benign lesions were diagnosed surgically. Five-year overall and cancer-specific survival were 78% (95% confidence interval, 72–84) and 82% (95% confidence interval, 76%–88%) respectively. Conclusions: The performance of the CT protocol was satisfactory with an acceptable number of benign lesions biopsied surgically, low recall rate, and good oncological outcomes. However, interval and advanced cancers, and misdiagnoses, need to be reduced, perhaps by risk modeling and use of serum markers.

[1]  M. L. R. D. Christenson,et al.  CT Screening for Lung Cancer: Diagnoses Resulting from the New York Early Lung Cancer Action Project , 2008 .

[2]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[3]  S. Sone,et al.  Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. , 2000, The British journal of radiology.

[4]  A. Dirksen,et al.  Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning , 2010, Thorax.

[5]  Lung cancer screening with low dose computed tomography: where do we stand today? , 2009 .

[6]  Massimo Bellomi,et al.  Lung Cancer Risk Prediction to Select Smokers for Screening CT—a Model Based on the Italian COSMOS Trial , 2011, Cancer Prevention Research.

[7]  Matthijs Oudkerk,et al.  Prospects for population screening and diagnosis of lung cancer , 2013, The Lancet.

[8]  J. Mulshine,et al.  Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. , 2008, Lung cancer.

[9]  M. Tsuboi,et al.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). , 2010, Japanese journal of clinical oncology.

[10]  James L Mulshine,et al.  Lung cancer screening. , 2005, The oncologist.

[11]  Stephen J. Swensen,et al.  Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. , 2008, Radiology.

[12]  Tony Hsiu-Hsi Chen,et al.  Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography , 2008, International journal of cancer.

[13]  Ugo Pastorino,et al.  Computed tomography screening and lung cancer outcomes. , 2007, JAMA.

[14]  R. Rami-Porta,et al.  The New Tumor, Node, and Metastasis Staging System , 2011, Seminars in respiratory and critical care medicine.

[15]  S. Swensen,et al.  Lung cancer screening with CT: Mayo Clinic experience. , 2003, Radiology.

[16]  A. Dirksen,et al.  The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  Kwang Pyo Kim,et al.  Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk , 2008, Journal of medical screening.

[18]  W. Travis,et al.  Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. , 2008, Lung cancer.

[19]  S. Ferretti,et al.  Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokers. , 2007, The British journal of radiology.

[20]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[21]  W. Heindel,et al.  Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers , 2004, European Radiology.

[22]  J. Austin,et al.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.

[23]  Harry J de Koning,et al.  Management of lung nodules detected by volume CT scanning. , 2009, The New England journal of medicine.

[24]  Dawei Yang.  Estimating overdiagnosis in low-dose computed tomography screening for lung cancer : a cohort study , 2013 .

[25]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[26]  G. Pelosi,et al.  Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. , 2008, The Journal of thoracic and cardiovascular surgery.

[27]  Does lung cancer screening with low-dose CT remain promising despite disappointing DANTE results? , 2010, American journal of respiratory and critical care medicine.

[28]  G. Pelosi,et al.  Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. , 2007, The Annals of thoracic surgery.